Dr Jones on Clinical Fracture Incidence in mHSPCByCraig Jones, MBChBMay 3rd 2023Craig Jones, MBChB, discusses findings from an analysis of fracture incidence in patients with metastatic hormone-sensitive prostate cancer from the phase 2/3 STAMPEDE trial platform protocol.